OVID THERAPEUTICS INC.

1.1000

25-November-24 15:45:01

15 minutes delayed

Stocks

+0.0500

+4.76%

Today's range

1.0700 - 1.1200

ISIN

N/A

Source

NASDAQ

Ovid Therapeutics to Participate in the 2021 RBC Capital Markets Global Healthcare Conference

12 May 2021 07:00:02 By Nasdaq GlobeNewswire
Ovid Therapeutics Announces Appointment of Professor Robert S. Langer, Sc.D., as Chair of its Scientific Advisory Board

20 Apr 2021 07:00:02 By Nasdaq GlobeNewswire
OVID Provides Update on OV101 Program and the Prioritization of its Resources

19 Apr 2021 07:00:01 By Nasdaq GlobeNewswire
Ovid Therapeutics Announces Closing of Agreement with Takeda for Global Development and Commercialization of Soticlestat

30 Mar 2021 07:00:01 By Nasdaq GlobeNewswire
Ovid Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results, Provides Corporate Update for 2021

15 Mar 2021 07:00:02 By Nasdaq GlobeNewswire

<<
<
1
2
3
4
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.